1st Circ. Revives Loestrin Pay-For-Delay Suit

By Kat Greene (February 22, 2016, 10:39 PM EST) -- Warner Chilcott will have to face claims it paid drugmakers to delay producing a generic version of its contraceptive Loestrin in multidistrict litigation after the First Circuit on Monday found that noncash settlements can be subject to antitrust scrutiny....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!